IMPORTANT LEGAL NOTICE : The information on this site is subject to a legal notice (http://europa.eu/geninfo/legal_notices_en.htm).
Europan Union Register of nutrition and health claims made on food - Rejected health claims
This page has moved ! If you are not redirected please click here

Rejected health claims



Article 14(1)(a) health claims referring to the reduction of a risk factor in the development of a disease


Nutrient, substance, food or food category
Claim
Reasons for rejection
EFSA opinion reference
Commission Regulation
ACTIMEL® Lactobacillus casei DN-114 001 plus yoghurt symbiosis Fermented milk containing the probiotic Lactobacillus casei DN-114 001 and yoghurt symbiosis decreases presence of Clostridium difficile toxins in the gut (of susceptible ageing people). Presence of Clostridium difficile toxins is associated with the incidence of acute diarrhoea. Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect Q-2009-00776 Commission Regulation (EU) No 1160/2011 of 14 November 2011 pdf
OPC Plus OPC Plus has been shown to increase the microcirculation and may therefore reduce the risk of chronic venous insufficiency Non-compliance with the Regulation as, on the basis of the dossier, the evidence provided did not establish that improving the “alterations in the venous microcirculation” is a beneficial physiological effect by reducing the risk of chronic venous insufficiency. A cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established Q-2009-00751 Commission Regulation (EU) No 665/2011 of 11 Julypdf
Soy protein Soy protein has been shown to lower/reduce blood cholesterol; blood cholesterol lowering may reduce the risk of (coronary) heart disease Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2009-00672 Commission Regulation (EU) No 1160/2011 of 14 November 2011 pdf
OPC Premium™, containing 40 mg oligomeric procyanidins (OPC) and 400 mg berry-blend per capsule. OPC have been shown to reduce blood cholesterol levels and may therefore reduce the risk of cardiovascular disease Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised with respect to the berry blend, whereas the active constituent extracted from grape (Vitis vinifera) seeds is sufficiently characterised
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2009-00454 COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010pdf
Uroval®, food supplement containing cranberry extract and D-mannose Cranberry extract and D-mannose, the main active ingredients of the food supplement Uroval®, eliminate the adhesion of harmful bacteria to the bladder wall. The adhesion of harmful bacteria to the bladder wall is the main risk factor in the development of urinary tract infections Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2009-00600 COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010pdf
Calcium containing fruit juices Reduced risk for dental erosion Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2009-00501 Commission Regulation (EU) No 1170/2011 of 16 November 2011pdf
BimunoTM (BGOS) Prebiotic Regular consumption of BimunoTM (BGOS) Prebiotic helps to protect against the bad bacteria than can cause the travellers’ diarrhoea Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2009-00232 Commission Regulation (EC) No 384/2010 of 5/05/2010pdf
Water Regular consumption of significant amounts of water can reduce the risk of development of dehydration and of concomitant decrease of performance Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, the proposed risk factors are measures of the disease and a risk factor in the development of a disease is not shown to be reduced. Q-2008-05014 Commission Regulation (EU) No 1170/2011 of 16 November 2011pdf
Lycopene-whey complex Lycopene-whey complex prevents oxidative damage of plasma lipoproteins, which reduces the build up of arterial plaques and reduces the risk of heart disease, stroke and other clinical complications of atherosclerosis Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-703 Commission Regulation (EC) No 384/2010 of 5/05/2010pdf
NeOpuntia®, containing dehydrated leaves of the prickly pear cactus (Opuntia ficus-indica) NeOpuntia® helps to improve blood lipid parameters associated with cardiovascular risks, especially the HDL-cholesterol. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-214 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Lactobacillus helveticus fermented Evolus® low-fat milk products Evolus® reduces arterial stiffness. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-218 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Melgaço® naturally sparkling mineral water The regular consumption of Melgaço mineral water reduces body hyperglycaemic levels Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-219 Commission Regulation (EC) No 1167/2009 of 30/11/2009PDF
Ocean Spray Cranberry Products®, juice drinks and sweetened dried berries Craisins® Regular consumption of 2 servings per day of an Ocean Spray product each containing typically 80 mg cranberry proanthocyanidins helps reduce the risk of urinary tract infection in women by inhibiting the adhesion of certain bacteria in the urinary tract Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-117 Commission Regulation (EC) No 1167/2009 of 30/11/2009PDF

Back to Top



Article 14(1)(b) health claims referring to children's development and health


Nutrient, substance, food or food category
Claim
Reasons for rejection
EFSA opinion reference
Commission Regulation
Immunofortis® Immunofortis® to naturally strengthen your baby’s immune system Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect Q-2008-106 Commission Regulation (EU) No 1162/2010 of 9 December 2010 refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and healthpdf
Docosahexaenoic acid (DHA) and arachidonic acid (ARA) Docosahexaenoic acid (DHA) and arachidonic acid (ARA) contribute to the optimal brain development of infants and young children. Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect Q-2008-212 Commission Regulation (EU) No 440/2011 of 6 May 2011 pdf
Lipil® Lipil® contributes to optimal brain development of infants and young children. Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect Q-2008-690 Commission Regulation (EU) No 440/2011 of 6 May 2011 pdf
Enfamil® Premium Enfamil® Premium contributes to optimal brain development of infants and young children. Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect

Q-2008-691

Commission Regulation (EU) No 440/2011 of 6 May 2011 pdf
Eye qTM Eye qTM (a unique combination of High-EPA/DHA/GLA omega-3, 6 PUFA) provides the essential nutrients that helps improve working memory in children Non-compliance with the Regulation as, on the basis of the dossier, the evidence submitted is insufficient to establish a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect Q-2009-00485 Commission Regulation (EU) No 1162/2010 of 9 December 2010 refusing to authorise certain health claims made on foods and referring to the reduction of disease risk and to children’s development and health pdf
Mixture of bifidobacteria (Bifidobacterium bifidum, Bifidobacterium breve, Bifidobacterium infantis, Bifidobacterium longum) Probiotic bifidobacteria lead to a healthy intestinal flora comparable to the composition of the intestinal flora of breast-fed infants’ intestine Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2009-00224 COMMISSION REGULATION (EU) No 957/2010 of 22 October 2010pdf
regulat®.pro.kid IMMUN, food supplement with fermented vegetables and fruits, probiotics lecithin and rhodiola rosea extract regulat®.pro.kid IMMUN supports, stimulates and modulates the immune system of children during growth. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-082 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
regulat®.pro.kid.BRAIN, food supplement with probiotics and fermented vegetables and fruits regulat®.pro.kid.BRAIN contributes to mental and cognitive development of children Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-083 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Calming Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-091 & Q-2008-096 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Provide serenity and room for a beneficial development of the child Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
- the effect has not been sufficiently defined
Q-2008-092 & Q-2008-097 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Helps to promote the thinking capacity Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-093 & Q-2008-101 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Help to promote concentration Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-094 & Q-2008-099 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Help to support vision Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-095 & Q-2008-100 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Help to support mental development Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-098 & Q-2008-104 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Docosahexaenoic Acid (DHA) and eicosapentaenoic acid (EPA) contained in I omega kids®/Pufan 3 kids® Help to support the learning ability Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-102 & EFSA-Q-2008-103 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Eye q baby®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Eye q baby® provides the nourishments that support healthy central nervous system development Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-119 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Eye q®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Eye q® provides the nourishments that help to maintain healthy brain functions Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-329 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Eye q®, containing  a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Eye q® provides the nourishment that help children to maintain concentration levels Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-330 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Mumomega®, containing a combination of the n-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and the n-6 PUFA gamma-linolenic acid (GLA) Mumomega® provides the nourishments that support healthy central nervous system development. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-328 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Docosahexaenoic Acid (DHA) and Arachidonic Acid (ARA) DHA & ARA support neural development of the brain and eyes. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-120 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain coordination. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-121 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain concentration. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-317 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain and support brain development and function. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-318 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain learning ability. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-319 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Efalex® products, containing eicosapentaenoic acid (EPA), the n-6 PUFA gamma-linolenic acid (GLA) and Arachidonic Acid (ARA) Efalex® may help maintain and support eye development and function. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-320 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Dairy products (milk, cheese and yoghurt) Three portions of dairy food everyday, as part of a balanced diet, may help promote a healthy body weight during childhood and adolescence. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-110 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
Dairy products (milk and cheese) Dairy foods (milk and cheese) promote dental health in children. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-112 Commission Regulation (EC) No 983/2009 of 21/10/2009pdf
LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum LACTORAL helps to bring back the normal functioning of the alimentary tract during its microflora disturbances (for example in case of loose stools, after taking antibiotics, in case of intestinal disorders caused by enteric pathogens). Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-269 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum LACTORAL is recommended in order to improve the general immunity by maintaining the microbiological balance. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-477 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum LACTORAL helps to protect the alimentary system against enteric pathogens because of strong antagonistic properties and helps to build the natural intestinal barrier. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-478 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum LACTORAL helps to maintain natural intestinal microflora during travel, changing the climatic zone or a diet, especially in poor hygiene conditions. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-479 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
LACTORAL, food supplement containing Lactobacillus plantarum, Lactobacillus rhamnosus and Bifidobacterium longum LACTORAL contains living probiotic bacteria with strong ability to intestinal tract colonisation, isolated from healthy, naturally fed-infant Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- the effect has not been sufficiently defined
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established
Q-2008-480 Commission Regulation (EC) No 1024/2009 of 29/10/2009pdf
Kinder Chocolate®, chocolate bar Kinder Chocolate, the chocolate that helps to grow Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-283 Commission Regulation (EC) No 1167/2009 of 30/11/2009PDF
Follow-on formulae with a fixed combination of short-chain galacto-oligosaccharides, acidified milk, nucleotides and beta-palmitate Aids minor intestinal ailments (as colic, constipation, digestive symptoms) Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-270 Commission Regulation (EC) No 1167/2009 of 30/11/2009PDF

Back to Top



Article 13(5) health claims based on newly developed scientific evidence and/or including a request for the protection of proprietary data


Nutrient, substance, food or food category
Claim
Reasons for rejection
EFSA opinion reference
Commission Regulation
Lactobacillus plantarum TENSIATM Regular consumption (at least three weeks) of 50 g/day Südamejuust ("heart cheese") of HarmonyTM brand comprising probiotic Lactobacillus plantarum TENSIATM helps to maintain the cardio-vascular system/heart health through reduction of blood pressure /symbol of heart

Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.

Q-2010-00950 Commission Regulation (EU) No 1171/2011 of 16 November 2011
Live Lactobacillus casei strain Shirota Daily consumption of live Lactobacillus casei strain Shirota as present in a fermented milk product helps maintain the upper respiratory tract defences by helping to support immune functions

Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.

Q-2010-00137 Commission Regulation (EU) No 1171/2011 of 16 November 2011
Ethanol-water extract of Caralluma fimbriata (Slimaluma®) Slimaluma® helps to control hunger/appetite

Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established

Q-2010-00031 Commission Regulation (EU) No 432/2011 of 4 May 2011
Ethanol-water extract of Caralluma fimbriata (Slimaluma®) Slimaluma® helps to reduce caloric intake

Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established

Q-2010-00030

Commission Regulation (EU) No 432/2011 of 4 May 2011
Ethanol-water extract of Caralluma fimbriata (Slimaluma®) Slimaluma® helps to reduce body weight

Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established

Q-2010-00029

Commission Regulation (EU) No 432/2011 of 4 May 2011

Ethanol-water extract of Caralluma fimbriata (Slimaluma®) Slimaluma® helps to reduce body fat Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established

Q-2010-00028

Commission Regulation (EU) No 432/2011 of 4 May 2011

Ethanol-water extract of Caralluma fimbriata (Slimaluma®) Slimaluma® helps to reduce waist circumference Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established Q-2010-00027 Commission Regulation (EU) No 432/2011 of 4 May 2011
Silymarin BIO-C® Suggested for improving the physiological production of breast milk during breast feeding Non-compliance with the Regulation as, on the basis of the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established Q-2009-00957 Commission Regulation (EU) No 666/2011 of 11 July 2011 pdf
Synbio Synbio persists in the intestinal tract and favours the natural regularity contributing to maintain and improve human intestinal well-being Non-compliance with the Regulation as, on the basis of the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established Q-2009-00889 Commission Regulation (EU) No 666/2011 of 11 July 2011 pdf
Catalgine® bouffées de chaleur Contributes to the reduction in the number of hot flushes Non-compliance with the Regulation as, on the basis of the evidence submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2009-00852 Commission Regulation (EU) No 1161/2010 of 9 December 2010 refusing to authorise a health claim made on foods, other than those referring to the reduction of disease risk and to children’s development and healthpdf
Combination of blackcurrant seed oil (Ribes nigrum), fish oil, lycopene from tomato (Lycopersicon esculentum) extract, vitamin C and vitamin E Helps to improve dry skin condition Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established

Q-2009-00767

Commission Regulation (EU) No 432/2011 of 4 May 2011
Immune Balance Drink, containing vitamin C, green tea extract, grape skin extract, grape seed extract, and shiitake mushroom extract The Immune Balance Drink activates body's defence Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2009-517 COMMISSION REGULATION (EU) No 958/2010 of 22 October 2010pdf
Lactobacillus plantarum 299v (DSM 9843) Lactobacillus plantarum 299v (DSM 9843) improves iron absorption Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-785 COMMISSION REGULATION (EU) No 375/2010 Of 3 May 2010pdf
Yestimun® Daily administration of Yestimun® strengthens the body’s defence during the cold season

Non-compliance with the Regulation as, on the basis of the data submitted in the dossier, a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established

Q-2008-667

Commission Regulation (EU) No 432/2011 of 4 May 2011
Milk product, rich in fibre and protein This product reduces the sense of hunger Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-396 COMMISSION REGULATION (EU) No 383/2010 Of 3 May 2010pdf
Natural Push-Up® Tablets and Natural Push-Up® Capsules NPU Tablets imitate female breasts enhancement process by 8-PN (8-Prenylnaringenin) Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-784 COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010pdf
Bimuno BT (BGOS) Prebiotic Helps maintain a healthy gastro-intestinal (GI) function Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2009-00231 COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010pdf
Bimuno BT (BGOS) Prebiotic Supports your natural defences Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2009-00230 COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010pdf
Gum Periobalance TM tablets and chewing gum Gum Periobalance TM , combined with a correct oral hygiene, helps re-balancing the oral microflora and improving oral health Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2009-00373 COMMISSION REGULATION (EU) No 382/2010 Of 3 May 2010pdf
Elancyl Global Silhouette®, a combined product containing either conjugated linoleic acid or a mix extract of plants and cocoa extract as active ingredients Clinically tested as of 14 days. Your silhouette is apparently and globally redrawn, resculpted and refined at 28 days. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- the food for which the claim is made has not been sufficiently characterised
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-285 Commission Regulation (EC) No 984/2009 of 21/10/2009pdf
LGG® MAX multispecies probiotic consisting of four bacterial trains LGG® MAX helps to reduce gastro-intestinal discomfort. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-444 Commission Regulation (EC) No 984/2009 of 21/10/2009pdf
Dairy product (milk beverage) enriched with milk peptide and magnesium Helps to moderate signs of anxiety in mildly stress-sensitive adults due to its milk peptide and magnesium content. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-476 Commission Regulation (EC) No 1025/2009 of 29/10/2009pdf
Black tea from Camellia sinensis Black tea helps you to focus attention. Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier,
- a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established.
Q-2008-434 Commission Regulation (EC) No 1025/2009 of 29/10/2009pdf
Algatrium®, containing DHA as raw material for foods/food supplements Algatrium® promotes your antioxidant response: a singular nutritional substance that has scientifically demonstrated in humans a stimulation of the own cells antioxidant defences Non-compliance with the Regulation as, on the basis of the evidence presented in the dossier, - a cause and effect relationship between the consumption of the food for which the claim is made and the claimed effect has not been established. Q-2008-705 Commission Regulation (EC) No 1168/2009 of 30/11/2009pdf

Back to Top